Capital Flow Monitor · Sponsors · CIK 1858288
Precision Neuroscience Corp
54 W 21st St., New York, NY, 10010 · 646-771-5881
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
—
Sold
$250.0M
% sold
—
Investors
46
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | D ·current | 506(b) | — | $250.0M | — | 46 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Michael Mager — Executive Officer / Director, New York, NY
- Konstantinos Alataris — Executive Officer / Director, New York, NY
- Craig Mermel — Executive Officer / Director, New York, NY
- Benjamin Rapoport — Executive Officer / Director, New York, NY
- Ravi Mehta — Director, New York, NY
- Howard Morgan — Director, New York, NY
- Michael Kaswan — Executive Officer, New York, NY
-
Michael Goller — Director, New York, NY
1 other raise
- Terremoto Biosciences, Inc. $40.7M of $108.6M · 37.5%
- Stephen Biggar — Director, New York, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.